0 Comments
0 Shares
736 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Asia-Pacific Melanoma Cancer Diagnostics Market Insights: Share, Size Report 2032Market Trends Shaping Executive Summary Asia-Pacific Melanoma Cancer Diagnostics Market Size and Share Asia-Pacific Melanoma Cancer Diagnostics Market Size The Asia-Pacific melanoma cancer diagnostics market size was valued at USD 694.93 million in 2024 and is expected to reach USD 1,315.13 million by 2032, at a CAGR of 8.3% during the forecast period...0 Comments 0 Shares 2K Views 0 Reviews
-
Asia-Pacific Ovarian Cancer Diagnostics Market: Biomarker Innovation Trends and Segment Analysis Forecast 2032"Executive Summary Asia-Pacific Ovarian Cancer Diagnostics Market Size and Share: Global Industry Snapshot Data Bridge Market Research analyses that the market is growing with a CAGR of 6.3% in the forecast period of 2023 to 2030 and is expected to reach USD 1,654.90 million by 2030 from USD 1,018.76 million in 2022. The Asia-Pacific Ovarian Cancer Diagnostics report is an ultimate...0 Comments 0 Shares 1K Views 0 Reviews
-
Asia-Pacific Ovarian Cancer Diagnostics Market: Precision Medicine Trends and Strategic Forecast 2032"Executive Summary Asia-Pacific Ovarian Cancer Diagnostics Market Size and Share: Global Industry Snapshot Asia-Pacific ovarian cancer diagnostics market is expected to grow in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.3% in the forecast period of 2023 to 2030 and is expected to reach USD 1,654.90 million by...0 Comments 0 Shares 1K Views 0 Reviews
-
Breast Cancer Diagnostics Market Projection: Steady Growth at 6.9% CAGRThe global landscape for breast cancer diagnostics is undergoing a fundamental shift from volume-based testing to value-based precision diagnostics. According to the latest strategic analysis by Fact.MR, the market, valued at USD 5,878 million in 2025, is poised to reach USD 6,389.41 million in 2026. This trajectory is set to continue at a steady 6.9% CAGR, propelling the industry to a...0 Comments 0 Shares 692 Views 0 Reviews
-
Cancer diagnostics: the largest karyotyping applicationMany cancers are driven by chromosomal abnormalities — translocations, deletions, or amplifications. Karyotyping and FISH are used to diagnose, classify, and monitor these cancers. The karyotyping market research study shows that cancer diagnostics holds the largest share, driven by the rising incidence of leukaemias, lymphomas, and solid tumours. What's tested? The...0 Comments 0 Shares 363 Views 0 Reviews
-
Digital Pathology and Genomic Profiling Driving Cancer Tissue Diagnostics Market GrowthThe global healthcare industry is witnessing remarkable growth in oncology diagnostics, with the Cancer Tissue Diagnostics Market playing a crucial role in early cancer detection and personalized treatment planning. Tissue diagnostics technologies are increasingly being adopted across hospitals, diagnostic laboratories, and research institutions to improve cancer diagnosis accuracy and support...0 Comments 0 Shares 134 Views 0 Reviews
-
ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Growth, Comprehensive Analysis Reveals Superb Development Analysis By FMINEWARK, DE / April 7, 2026 / The global ESR1 mutated metastatic breast cancer diagnostics market is projected to grow from USD 64.61 million in 2025 to USD 92.92 million by 2035, registering a CAGR of 3.7%. Growth is driven by the rising prevalence of ESR1 mutations in metastatic breast cancer patients, increasing adoption of precision medicine, and advancements in...0 Comments 0 Shares 421 Views 0 Reviews
-
Europe Melanoma Cancer Diagnostics Market Trends Report: Size & Forecast Overview 2032Executive Summary Europe Melanoma Cancer Diagnostics Market Size and Share Across Top Segments Europe Melanoma Cancer Diagnostics Market Size The Europe melanoma cancer diagnostics market size was valued at USD 1.55 billion in 2024 and is expected to reach USD 2.59 billion by 2032, at a CAGR of 6.6% during the forecast period The market growth is largely...0 Comments 0 Shares 1K Views 0 Reviews
-
Europe Ovarian Cancer Diagnostics Market Size, Share, and Regulatory Policy Impact Forecast 2032"Executive Summary Europe Ovarian Cancer Diagnostics Market Research: Share and Size Intelligence Data Bridge Market Research analyses that the market is growing with a CAGR of 6.5% in the forecast period of 2023 to 2030 and is expected to reach USD 3,093.84 million by 2030 from USD 1,874.16 million in 2022. This Europe Ovarian Cancer Diagnostics Market research report is a...0 Comments 0 Shares 1K Views 0 Reviews
-
Europe Ovarian Cancer Diagnostics Market Size, Share, Biomarker Trends and Strategic Forecast 2032"Executive Summary Europe Ovarian Cancer Diagnostics Market Size and Share Analysis Report Data Bridge Market Research analyses that the market is growing with a CAGR of 6.5% in the forecast period of 2023 to 2030 and is expected to reach USD 3,093.84 million by 2030 from USD 1,874.16 million in 2022. the Europe Ovarian Cancer Diagnostics Market analysis report, the strength and...0 Comments 0 Shares 1K Views 0 Reviews
-
Healthcare Infrastructure Trends MEA Ovarian Cancer Diagnostics Market Share and Strategic Forecast 2032"Global Demand Outlook for Executive Summary Middle East and Africa Ovarian Cancer Diagnostics Market Size and Share Middle East and Africa ovarian cancer diagnostics market is expected to grow in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.1% in the forecast period of 2023 to 2030 and is expected to reach USD...0 Comments 0 Shares 1K Views 0 Reviews
-
10. Global Prostate Cancer Diagnostic Solutions Market Projected to Hit USD 13.1 Billion by 2036The global landscape for prostate cancer diagnostics is undergoing a fundamental structural shift, driven by a transition from legacy screening methods to high-precision, AI-integrated molecular imaging. According to the latest market analysis by Fact.MR, the Prostate Cancer Diagnostics Market was valued at USD 5.06 billion in 2026 and is projected to surge to USD 13.12...0 Comments 0 Shares 818 Views 0 Reviews
-
Are Medical Cyclotrons Advancing Precision in Cancer Diagnosis and Treatment?Regional Overview of Executive Summary Medical Cyclotron Market by Size and Share CAGR Value The global medical cyclotron market size was valued at USD 228.20 million in 2025 and is expected to reach USD 466.85 million by 2033, at a CAGR of 9.36% during the forecast period The market report also contains the drivers and restraints for the Medical...0 Comments 0 Shares 2K Views 0 Reviews
-
China Clinical Trials Market: How Is the China Clinical Trials Market Strengthening Site‑Infrastructure and Investigator‑Capacity?The China Clinical Trials Market is strengthening site‑infrastructure and investigator‑capacity, turning major‑hospitals and research‑centers into professional‑clinical‑trial‑platforms. China Clinical Trials Market Investment in GCP‑compliant‑sites Leading‑hospitals are upgrading facilities, electronic‑data‑capture‑systems, and monitoring‑processes to meet global‑GCP‑standards....0 Comments 0 Shares 155 Views 0 Reviews
-
How Is Bone Marrow Biopsy Advancing Cancer Diagnosis?Key Drivers Impacting Executive Summary Bone Marrow Biopsy Market Size and Share CAGR Value Data Bridge Market Research analyses a significant growth in the global bone marrow biopsy market in the forecast period 2022-2029. The expected CAGR of global bone marrow biopsy market is tend to be around 6.3% in the mentioned forecast period The report explains the vital developments about...0 Comments 0 Shares 918 Views 0 Reviews
More Results
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek